Granite Point Capital Management, L.P. Tela Bio, Inc. Transaction History

Granite Point Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$6.5 - $11.5 $727,902 - $1.29 Million	-111,985 Reduced 49.19%	115,659 $1.33 Million
Q3 2021 Nov 10, 2021	BUY	$12.2 - $15.93 $337,256 - $440,368	27,644 Added 13.82%	227,644 $3.11 Million
Q2 2021 Aug 16, 2021	BUY	$11.7 - $16.11 $2.34 Million - $3.22 Million	200,000 New	200,000 $3.22 Million

18.3M

759K

100

Ticker TELA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,157,600
Market Cap $55.4M
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.